Cargando…
Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure
OBJECTIVE: Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol. Here we analyzed the effects of zolmitriptan on portal pressure and its potential interaction with propranolol. METHODS: Zolmitriptan, propranolol or bot...
Autores principales: | Reboredo, Mercedes, Chang, Haisul C. Y., Barbero, Roberto, Rodríguez-Ortigosa, Carlos M., Pérez-Vizcaíno, Francisco, Morán, Asunción, García, Mónica, Banales, Jesús M., Carreño, Norberto, Alegre, Félix, Herrero, Ignacio, Quiroga, Jorge, Prieto, Jesús, Sangro, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547109/ https://www.ncbi.nlm.nih.gov/pubmed/23341903 http://dx.doi.org/10.1371/journal.pone.0052683 |
Ejemplares similares
-
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014) -
Propranolol Reduces Portal Vein Diameter in Schistosomal Liver Disease with Portal Hypertension: A Prospective Cohort Study
por: Sinkala, Edford, et al.
Publicado: (2020) -
The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis
por: Chen, Sheng, et al.
Publicado: (2015) -
Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study
por: Lim, Yoo Li, et al.
Publicado: (2017) -
Systemic exposure to propranolol in patients with chronic liver disease and its correlation with portal blood flow
por: Kim, Tae-Eun, et al.
Publicado: (2022)